Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1

BACKGROUND: There are around 350 million of hepatitis B surface antigen (HBsAg) carriers worldwide, and among them, high risk of developing hepatocellular carcinoma (HCC) has been identified by epidemiological studies. To date, the molecular role of HBsAg in HCC development has not been fully studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xiaochen, Li, Jinjun, Ma, Zhang-Mei, Zhao, Chao, Wan, Da-Fang, Wen, Yu-Mei
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678988/
https://www.ncbi.nlm.nih.gov/pubmed/19402906
http://dx.doi.org/10.1186/1756-9966-28-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678988/
https://www.ncbi.nlm.nih.gov/pubmed/19402906
http://dx.doi.org/10.1186/1756-9966-28-58

Ejemplares similares